Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export and supplierofEtoposide Injectionfrom Surat, Gujarat, India. Etoposide Injection used for the treatments of a number of types of cancer including testicular cancer, lung cancer, lymphoma, leukemia, neuroblastoma, and ovarian cancer.
Tags: Etoposide Injection manufacturer, Etoposide Injection exporter,Etoposide Injection supplier, and Etoposide Injection, whogmp approved Etoposide Injectionmanufacturer and supplier, Etoposide Injection distributor, Etoposide Injectionshipper, Etoposide Injection 20 mg Etoposide Injection 20 mgsupplier,Etoposide Injection 20 mg.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceEtoposide Injection export toUSA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Precise Indication and Clinical UseEtoposide Injection is specially indicated for the management of small cell lung cancer and testicular cancer, administered exclusively via intravenous infusion by healthcare professionals. Its well-defined clinical applications ensure targeted therapy under physician guidance, optimizing patient outcomes.
Stringent Quality and Safety MeasuresManufactured to comply with USP and other pharmacopeial standards, this injection upholds high-quality benchmarks. It is essential for users, especially dealers and distributors in India, to handle it as a cytotoxic agent with proper safety precautions due to its hazardous nature.
FAQ's of Etoposide Injection:
Q: How is Etoposide Injection administered?
A: Etoposide Injection is administered exclusively as an intravenous (IV) infusion under the supervision of a qualified healthcare professional in hospitals or clinics.
Q: What cancers is Etoposide Injection used to treat?
A: This medication is primarily indicated for the treatment of small cell lung cancer and testicular cancer, as prescribed by a physician.
Q: When should Etoposide Injection not be used?
A: Etoposide Injection must not be used in patients with known hypersensitivity to etoposide or any excipients in the formulation, including benzyl alcohol.
Q: Where should Etoposide Injection be stored for maximum shelf life?
A: To maintain its stability and effectiveness, the injection should be stored in a cool and dry place, away from direct sunlight, and used within its two-year shelf life.
Q: What precautions are needed in handling Etoposide Injection?
A: As a cytotoxic and hazardous substance, proper handling equipment and protective measures are required throughout the supply and administration process to avoid accidental exposure.
Q: What are the benefits of using Etoposide Injection in cancer therapy?
A: Etoposide Injection offers significant clinical benefits by targeting specific types of cancer, helping to inhibit cancer cell growth and improve patient prognosis when incorporated into treatment regimens under medical supervision.